Woodline Partners LP

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1784547 San Francisco, CA

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$64,442,188

+$33,373,056 QoQ

Shares Held

200,013

+89.7% QoQ

Ownership

0.717%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,423,987,323 across 188 Biotechnology names. PRAX ranks #11 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$64,442,188	200,013	+89.7%	Shares	Sole	2026-05-15
2025-12-31	$31,069,132	105,412	-74.8%	Shares	Sole	2026-02-17
2025-09-30	$22,136,457	417,669	+808.9%	Shares	Sole	2025-11-14
2025-06-30	$1,932,281	45,952	-73.9%	Shares	Sole	2025-08-14
2025-03-31	$6,654,781	175,727	+1666.5%	Shares	Sole	2025-05-15
2024-12-31	$765,598	9,948	-63.5%	Shares	Sole	2025-02-14
2024-03-31	$1,663,588	27,263	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.